Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2

2(50.0%)

N/A

1(25.0%)

Early Phase 1

1(25.0%)

4Total

Phase 2(2)

N/A(1)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT06985095Not ApplicableRecruiting

Evaluation of a Structured Nutrition Educational Program in Insulin-treated Diabetic Patients in Vietnam

Role: lead

NCT04449211Early Phase 1Recruiting

The Effectiveness in the Treatment of Long Bone Defect Using 3D-printed Implant

Role: lead

NCT05362825Unknown

Surgery Outcome Treated by Neo-adjuvant Combination of Oxaliplatin, Irinotecan, Folinic Acid and Fluorouracil (FOLFOXIRI) Regimen in Synchronous Liver Limited Metastasis Colorectal Cancer

Role: lead

NCT04328493Phase 2Completed

The Vietnam Chloroquine Treatment on COVID-19

Role: collaborator

NCT03112031Phase 2Completed

Treatment With Tamoxifen in Cryptococcal Meningitis

Role: collaborator

All 5 trials loaded